Showing results (251-260 of 295) with videos related to
Sort By:
Pageof 30
The Journal of Clinical Endocrinology and Metabolism|May 11, 2006
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapyC Durante, N Haddy, E Baudin, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 30, 2017
No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancerS I Sherman, R T Kloos, R M Tuttle, et al.Annales D'Endocrinologie|April 6, 1999
[Von Hippel-Lindau disease: recent genetic progress and patient management. Francophone Study Group of von Hippel-Lindau Disease (GEFVH)]S Richard, S Giraud, C Beroud, et al.Pediatric Hematology and Oncology|September 1, 1997
Pheochromocytoma and paraganglioma in children: a report of 24 cases of the French Society of Pediatric OncologyY Perel, M Schlumberger, G Marguerite, et al.European Journal of Endocrinology|November 27, 1999
Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC)P Niccoli-Sire, A Murat, E Baudin, et al.Clinical Endocrinology|May 14, 1998
Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonineE Modigliani, R Cohen, J M Campos, et al.Hormones & Cancer|December 14, 2011
Therapeutic management of advanced adrenocortical carcinoma: what do we know in 2011?E Baudin, S Leboulleux, A Al Ghuzlan, et al.Oncogene|August 16, 2011
ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescenceU Weyemi, O Lagente-Chevallier, M Boufraqech, et al.The Journal of Clinical Endocrinology and Metabolism|January 27, 1999
Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumorsE Baudin, J M Bidart, P Rougier, et al.Endocrine-Related Cancer|December 25, 2010
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin levelC Nascimento, I Borget, A Al Ghuzlan, et al.Pageof 30